組織再生材料:医療機器パイプライン分析

◆英語タイトル:Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0140
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Tissue Regenerative Materials – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Tissue Regenerative Materials – Medical Devices Pipeline Assessment, 2019″ provides an overview of Tissue Regenerative Materials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Regenerative Materials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Tissue Regenerative Materials under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Regenerative Materials under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Tissue Regenerative Materials Overview 6
3 Products under Development 7
3.1 Tissue Regenerative Materials – Pipeline Products by Stage of Development 7
3.2 Tissue Regenerative Materials – Pipeline Products by Territory 8
3.3 Tissue Regenerative Materials – Pipeline Products by Regulatory Path 9
3.4 Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 10
4 Tissue Regenerative Materials – Pipeline Products under Development by Companies 11
4.1 Tissue Regenerative Materials Companies – Pipeline Products by Stage of Development 11
4.2 Tissue Regenerative Materials – Pipeline Products by Stage of Development 12
5 Tissue Regenerative Materials Companies and Product Overview 13
5.1 Biora AB Company Overview 13
5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Collagen Matrix Inc Company Overview 14
5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Colorado Therapeutics, LLC Company Overview 16
5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 credentis AG Company Overview 17
5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Gene Techno Science Co Ltd Company Overview 18
5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
6 Tissue Regenerative Materials- Recent Developments 31
6.1 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication’s Industry Relations Committee 31
6.2 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update 31
6.3 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team 33
6.4 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28% 34
6.5 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business 40
6.6 Jun 19, 2019: CelGro accelerates dental implant treatment 40
6.7 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update 42
6.8 May 23, 2019: Full availability of Geistlich Fibro-Gide, the alternative soft-tissue graft 44
6.9 May 23, 2019: Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets 45
6.10 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel 46
6.11 May 16, 2019: CURODONT REPAIR is the superior treatment for white spots 46
6.12 May 01, 2019: Orthocell submits AUS regulatory application for CelGro 46
6.13 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter 47
6.14 Apr 11, 2019: CURODONT REPAIR FLUORIDE PLUS – distribution starts in the US 49
6.15 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update 50
6.16 Feb 20, 2019: CURODONT PROTECT – Best Prophylaxis during Orthodontic Treatment 52
6.17 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30% 52
6.18 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board 57
6.19 Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development 58
7 Appendix 59
7.1 Methodology 59
7.2 About GlobalData 62
7.3 Contact Us 62
7.4 Disclaimer 62

List of Tables
Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
Table 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
Table 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10
Table 5: Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development 11
Table 6: Tissue Regenerative Materials - Pipeline Products by Stage of Development 12
Table 7: Biora AB Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: Straumann Emdogain FL - Product Status 13
Table 9: Straumann Emdogain FL - Product Description 13
Table 10: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: MatrixMem - Product Status 14
Table 12: MatrixMem - Product Description 14
Table 13: Socket Repair Kit - Product Status 15
Table 14: Socket Repair Kit - Product Description 15
Table 15: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 16
Table 16: Xenograft Implant - Dental - Product Status 16
Table 17: Xenograft Implant - Dental - Product Description 16
Table 18: credentis AG Pipeline Products & Ongoing Clinical Trials Overview 17
Table 19: CUROLOX Perio - Product Status 17
Table 20: CUROLOX Perio - Product Description 17
Table 21: Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
Table 22: GCT-101 - Product Status 18
Table 23: GCT-101 - Product Description 18
Table 24: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 19
Table 25: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status 19
Table 26: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description 19
Table 27: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 20
Table 28: Electrospun Scaffold - Product Status 20
Table 29: Electrospun Scaffold - Product Description 20
Table 30: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 31: MaxiGuide - Product Status 21
Table 32: MaxiGuide - Product Description 21
Table 33: Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 22
Table 34: Bone Inductive Implant - Product Status 22
Table 35: Bone Inductive Implant - Product Description 22
Table 36: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 23
Table 37: OrthoNovaOss - Product Status 23
Table 38: OrthoNovaOss - Product Description 23
Table 39: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
Table 40: CelGro - Dental - Product Status 24
Table 41: CelGro - Dental - Product Description 24
Table 42: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 25
Table 43: Inorganic Dental Cement - Product Status 25
Table 44: Inorganic Dental Cement - Product Description 26
Table 45: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 27
Table 46: Soft Tissue Control Implant - Product Status 27
Table 47: Soft Tissue Control Implant - Product Description 27
Table 48: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: DentaColl - Product Status 28
Table 50: DentaColl - Product Description 28
Table 51: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 52: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status 29
Table 53: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description 29
Table 54: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 30
Table 55: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 30
Table 56: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 30
Table 57: Glossary 61

List of Figures
Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development 7
Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory 8
Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path 9
Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date 10

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[組織再生材料:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆